BioNexus Gene Lab (BGLC) Competitors $0.30 0.00 (0.00%) (As of 02:00 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BGLC vs. CCM, MRAI, OPGN, PMD, TOI, BRTX, OTRK, ATIP, MGRX, and ATPCShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Concord Medical Services (CCM), Marpai (MRAI), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Concord Medical Services Marpai OpGen Psychemedics Oncology Institute BioRestorative Therapies Ontrak ATI Physical Therapy Mangoceuticals Agape ATP Concord Medical Services (NYSE:CCM) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, community ranking, institutional ownership, dividends, risk, profitability, media sentiment and valuation. Which has better earnings & valuation, CCM or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$75.69M0.28-$41.93MN/AN/ABioNexus Gene Lab$9.77M0.55-$2.63MN/AN/A Is CCM or BGLC more profitable? Concord Medical Services has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -10.17%. Concord Medical Services' return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioNexus Gene Lab -10.17%-9.93%-8.43% Does the media favor CCM or BGLC? In the previous week, Concord Medical Services had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for BioNexus Gene Lab. Concord Medical Services' average media sentiment score of 0.00 equaled BioNexus Gene Lab'saverage media sentiment score. Company Overall Sentiment Concord Medical Services Neutral BioNexus Gene Lab Neutral Which has more risk and volatility, CCM or BGLC? Concord Medical Services has a beta of -0.27, indicating that its stock price is 127% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 7.71, indicating that its stock price is 671% more volatile than the S&P 500. Does the MarketBeat Community believe in CCM or BGLC? Concord Medical Services received 197 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19762.54% Underperform Votes11837.46% BioNexus Gene LabN/AN/A Do insiders and institutionals hold more shares of CCM or BGLC? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Comparatively, 2.0% of BioNexus Gene Lab shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryConcord Medical Services beats BioNexus Gene Lab on 7 of the 11 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.39M$3.11B$5.10B$8.84BDividend YieldN/A11.18%5.04%4.07%P/E RatioN/A10.6095.1214.22Price / Sales0.55219.821,217.3088.42Price / CashN/A406.7839.4936.27Price / Book0.583.236.976.37Net Income-$2.63M-$32.86M$118.73M$225.56M7 Day Performance-6.25%1.89%-1.22%-0.02%1 Month Performance-18.70%1.12%-3.07%2.04%1 Year Performance-15.01%27.06%32.52%28.00% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene LabN/A$0.30flatN/A-22.6%$5.39M$9.77M0.0030CCMConcord Medical Services0.3433 of 5 stars$4.84+15.2%N/A-58.6%$21.01M$75.69M0.00970MRAIMarpai2.0113 of 5 stars$1.44-12.2%$6.00+316.7%+80.2%$19.79M$37.15M-0.62150OPGNOpGenN/A$1.81-9.0%N/A-55.8%$15.13M$3.42M0.00100News CoverageGap DownPMDPsychemedics0.7025 of 5 stars$2.34flatN/A+11.0%$13.78M$22.10M-4.57140TOIOncology Institute2.3302 of 5 stars$0.15+11.4%$2.50+1,597.2%-94.1%$11.12M$324.24M0.00660Gap UpHigh Trading VolumeBRTXBioRestorative Therapies3.7191 of 5 stars$1.41+0.8%$18.00+1,175.3%-22.2%$9.77M$150,000.00-0.927Analyst RevisionNews CoverageGap UpOTRKOntrak2.7325 of 5 stars$1.81-1.1%$45.00+2,386.2%-79.4%$7.64M$12.74M0.00250ATIPATI Physical Therapy0.2281 of 5 stars$1.53-3.8%N/A-78.2%$6.75M$699.02M0.005,600High Trading VolumeMGRXMangoceuticals0.508 of 5 stars$2.54+2.8%N/A-98.1%$6.33M$730,000.000.003Gap DownATPCAgape ATP0.013 of 5 stars$1.48+2.8%N/A-92.4%$5.91M$1.43M0.0040 Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives OPGN Alternatives PMD Alternatives TOI Alternatives BRTX Alternatives OTRK Alternatives ATIP Alternatives MGRX Alternatives ATPC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGLC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BGLC Stock Alerts